Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 153.27
-0.013 %
$ 15.5 B
Market Cap
40.87
P/E
NBIX - TOTAL CURRENT ASSETS
Total Current Assets NBIX - Neurocrine Biosciences, Inc.
1.61 B
LAST VALUE
28.53%
2 YEAR CAGR
16.85%
5 YEAR CAGR
26.89%
10 YEAR CAGR